On January 22, 2026, the Food and Drug Administration (FDA) held a public meeting to evaluate the advertising proposal from Philip Morris International regarding its nicotine pouch product, Zyn. This product has gained popularity in the adult demographic, particularly among individuals in their 30s and 40s. Previously, in January 2025, the FDA authorized Zyn to remain on the market, citing findings that indicated it was less harmful when compared to traditional tobacco products like cigarettes. The ruling was met with both regulatory enthusiasm and apprehension from public health advocates. During the review process, the FDA's tobacco control staff asserted that the claim that Zyn could reduce the risk of smoking-related illnesses is supported by scientific evidence. While Philip Morris has not conducted long-term health studies on Zyn users, their existing research showcased that Zyn contained lower levels of harmful substances than conventional tobacco products. Notably, the company's similar product, snus, has been associated with lower incidences of lung and mouth cancers in Scandinavian countries, suggesting potential benefits of using Zyn. Despite the encouraging data presented, the popularity of Zyn has raised concerns among anti-tobacco groups. A study by the Truth Initiative highlighted a worrying trend of increased product sales following viral social media posts featuring young influencers promoting Zyn. This surge in visibility on platforms like TikTok has triggered debates about the marketing strategies employed by tobacco companies and their impact on youth and public health. The upcoming FDA decision could have significant implications for the tobacco industry, particularly as Zyn represents one of the fastest-growing segments within this sector, which has been struggling to maintain revenue in the face of declining cigarette use. Should the FDA approve the marketing of Zyn with reduced-risk claims, this would signal a notable shift in how nicotine products are perceived and marketed to consumers, potentially inviting further scrutiny and discussion about the ethical ramifications of such advertisements aimed at adult smokers looking for alternatives to cigarettes.